Create account

Coverage dated November 4, 2026 to November 5, 2026

Oxford vaccine moves towards pivotal trial against deadly Bundibugyo Ebola virus

Headline from Digital Journal

An experimental vaccine developed at Oxford is set to move into a pivotal Phase 2/3 study in the Democratic Republic of the Congo, potentially bringing scientists closer to the first vaccine specifically approved against Bundibugyo virus.

Digital Journal's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

5 articles, oldest first.

  1. WFMZ Allentown

    WHO approves clinical trials on two new Ebola vaccines (opens WFMZ Allentown)

    Published

    WFMZ Allentown's feed description

    The World Health Organization on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.

  2. Al Jazeera

    WHO approves trials for two new Ebola vaccines (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    Two new vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.

  3. Latin Times

    WHO Backs 2 New Ebola Vaccines for Trial. 5,300+ Dead. Results Not Until 2027 (opens Latin Times)

    Published

    Latin Times's feed description

    WHO expert groups have recommended Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469 for the DRC's Tumaini trial, the first active-outbreak test of vaccines targeting Bundibugyo Ebola.

  4. Digital Journal

    Oxford vaccine moves towards pivotal trial against deadly Bundibugyo Ebola virus (opens Digital Journal)

    Published

    Digital Journal's feed description

    An experimental vaccine developed at Oxford is set to move into a pivotal Phase 2/3 study in the Democratic Republic of the Congo, potentially bringing scientists closer to the first vaccine specifically approved against Bundibugyo virus.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Oxford vaccine moves towards pivotal trial against deadly Bundibugyo Ebola virus | Since Then